John Nicholson, SVP & Chief Operating Officer at NEKTAR THERAPEUTICS (NKTR), sold 8,154 shares at $31.37 ($256K) on 2019-05-16, disclosed to the SEC on 2019-05-17.
Seasonal sale ($256k) by SVP & Chief Operating Officer — this insider has traded NKTR in May in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $31.37 | 4,077 | $128K | 50.0% |
| 2 | $31.37 | 4,077 | $128K | 50.0% |
| Total | $31.37 avg | 8,154 | $256K | 100% |
| Filing → |
| NKTR | SELL | 2019-01-30 | $2.7M | — | Filing → |
| NKTR | SELL | 2018-11-19 | $458K | — | Filing → |
| NKTR | SELL | 2018-05-18 | $820K | — | Filing → |